Melarsoprol: Clinical Trials

1 trial of Melarsoprol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Melarsoprol: new trials by email Literature Review of Melarsoprol trials Research Report on Melarsoprol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis
melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d, melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d, nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d - Trypanosomiasis, African
Phase 3TerminatedEpicentre4352001-03-012006-05-26

Conditions studied

Trypanosomiasis (1)  ·  Trypanosomiasis, African (1)

Sponsors

Epicentre (1)

Countries

Uganda (1)

Top investigators

Gerardo Priotto, MD, MPH (1)